Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab plus radiotherapy and temozolomide in primary glioblastoma multiforme
2007-005644-24Phase 2Active
- Sponsor
- Amsterdam UMC
- Start
- Oct 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, temozolomide in glioblastoma (GBM), glioma, sponsored by Amsterdam UMC. Started Oct 2007; status: active.
02
Drugs
bevacizumabtemozolomide
03
Conditions
glioblastoma (GBM)glioma
Beyond the preview
Go deeper on 2007-005644-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005644-24.